NAGE · Niagen Bioscience, Inc. · Documents
$2.50
+0.06 (+2.46%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$193.07M
Shares
79.13M
Volume · Oct 27
473.48K
Avg daily vol (3M)
546.87K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-03-06 | — | |
| 8-K | — | 2023-12-13 | 2023-12-08 | |
| 10-Q | — | 2023-11-08 | 2023-09-30 | |
| 8-K | — | 2023-11-08 | — | |
| 8-K | — | 2023-08-09 | — | |
| 10-Q | — | 2023-08-09 | 2023-06-30 | |
| S-3 | — | 2023-06-22 | — | |
| 8-K | — | 2023-06-20 | 2023-06-15 | |
| 10-Q | — | 2023-05-10 | 2023-03-31 | |
| 8-K | — | 2023-05-10 | — | |
| DEF 14A | — | 2023-04-28 | — | |
| DEFA14A | — | 2023-04-28 | — | |
| ARS | — | 2023-04-28 | 2022-12-31 | |
| PRE 14A | — | 2023-04-19 | — | |
| 8-K | — | 2023-03-17 | 2023-03-16 | |
| 8-K | — | 2023-03-08 | — | |
| 10-K | — | 2023-03-08 | 2022-12-31 | |
| 8-K | — | 2023-01-05 | 2023-01-03 | |
| S-3 | — | 2022-11-03 | — | |
| 10-Q | — | 2022-11-02 | 2022-09-30 | |
| 8-K | — | 2022-11-02 | — | |
| 8-K | — | 2022-10-11 | 2022-10-10 | |
| 8-K | — | 2022-10-03 | 2022-09-30 | |
| 10-Q | — | 2022-08-10 | 2022-06-30 | |
| 8-K | — | 2022-08-10 | 2022-08-08 | |
| 8-K | — | 2022-06-21 | 2022-06-16 | |
| 8-K | — | 2022-06-09 | 2022-06-03 | |
| 8-K | — | 2022-05-19 | — | |
| 8-K | — | 2022-05-12 | — | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| DEFA14A | — | 2022-04-27 | — | |
| DEF 14A | — | 2022-04-27 | 2022-06-16 | |
| 8-K | — | 2022-04-18 | 2022-04-14 | |
| 8-K | — | 2022-04-15 | 2022-04-11 | |
| 8-K | — | 2022-04-11 | 2022-04-05 | |
| 8-K | — | 2022-04-08 | 2022-04-04 | |
| 8-K | — | 2022-03-23 | — | |
| 10-K | — | 2022-03-14 | 2021-12-31 | |
| 8-K | — | 2022-03-09 | — | |
| 8-K | — | 2021-12-15 | 2021-12-11 | |
| 8-K | — | 2021-12-13 | — | |
| 8-K | — | 2021-12-01 | — | |
| 8-K | — | 2021-11-03 | — | |
| 10-Q | — | 2021-11-03 | 2021-09-30 | |
| 8-K | — | 2021-10-29 | 2021-10-19 | |
| 8-K | — | 2021-09-30 | 2021-09-27 | |
| 8-K | — | 2021-09-15 | 2021-09-14 | |
| 10-Q | — | 2021-08-03 | 2021-06-30 | |
| 8-K | — | 2021-08-03 | — | |
| 8-K | — | 2021-06-22 | 2021-06-17 |
Showing 51–100 of 131 filings
Key facts
CIK
1386570
CUSIP
171077407
13F (30d)
17 filings
16 filers
Visit website
Investor relations